CVS Health Corporation (CVS) is a leading healthcare plans business based in the US. It opened the day at $90.64 after a previous close of $89.99. During the day the price has varied from a low of $90.11 to a high of $91.59. The latest price was $90.87 (25 minute delay). CVS Health Corporation is listed on the NYSE and employs 213,000 staff. All prices are listed in US Dollars.
Best for
Low-cost
Best for
Beginners
Best for
Funds
Best for
Range of markets
Since the stock market crash that started in February 2020, CVS Health Corporation's share price has had significant positive movement.
Its last market close was $101.56, which is 29.59% up on its pre-crash value of $71.51 and 95.16% up on the lowest point reached during the March 2020 crash when the shares fell as low as $52.04.
If you had bought $1,000 worth of CVS Health Corporation shares at the start of February 2020, those shares would have been worth $793.16 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,517.31.
| Open | $90.64 |
|---|---|
| High | $91.59 |
| Low | $90.11 |
| Close | $90.87 |
| Previous close | $89.99 |
| Change | $0.88 |
| Change % | 0.9779% |
| Volume | 5,660,063 |
| 52-week range | $66.7817 - $107.26 |
|---|---|
| 50-day moving average | $97.7656 |
| 200-day moving average | $87.0464 |
| Wall St. target price | $113.04 |
| PE ratio | 16.8246 |
| Dividend yield | $2 (2.07%) |
| Earnings per share (TTM) | $5.7217 |
Other fees apply. Your capital is at risk.
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $10 | £3.38 £679.27 total |
Capital at risk |
 |
£0 | £0.01 | £1.69 £677.58 total |
Capital at risk |
 |
£0 | £50 | £3.38 £679.27 total |
Capital at risk |
|
£0 | £250 | £10.85 £686.75 total |
Capital at risk |
 |
£0 | £1 | £18.71 £694.60 total |
Capital at risk |
|
£9.99 per month | No minimum | £18.13 £694.02 total |
Capital at risk |
 |
£0 | No minimum | £6.76 £682.65 total |
Capital at risk |
 |
£36 per year | £20 | £17.95 £693.84 total |
Capital at risk |
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
CVS Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, CVS Health Corporation shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CVS Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0889. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CVS Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CVS Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $17.8 billion (£13.3 billion).
The EBITDA is a measure of a CVS Health Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $284 billion |
|---|---|
| Operating margin TTM | 4.68% |
| Gross profit TTM | $48.2 billion |
| Return on assets TTM | 3.55% |
| Return on equity TTM | 1060.13% |
| Profit margin | 2.67% |
| Book value | $56.251 |
| Market capitalisation | $140.2 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CVS Health Corporation.
CVS Health Corporation's total ESG risk: 18.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CVS Health Corporation's overall score of 18.73 (as at 12/31/2018) is excellent – landing it in it in the 19th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CVS Health Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
CVS Health Corporation's environmental score: 1.92/100
CVS Health Corporation's social score: 9.06/100
CVS Health Corporation's governance score: 2.75/100
CVS Health Corporation's controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, CVS Health Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that CVS Health Corporation hasn't always managed to keep its nose clean.
CVS Health Corporation was last rated for ESG on: 2019-01-01.
| Total ESG score | 18.73 |
|---|---|
| Total ESG percentile | 18.84 |
| Environmental score | 1.92 |
| Social score | 9.06 |
| Governance score | 2.75 |
| Level of controversy | 3 |
Dividend yield: 2.07% of stock value
Forward annual dividend yield: 2.07% of stock value
Dividend payout ratio: 26.52% of net profits
CVS Health Corporation has recently paid out dividends equivalent to 2.07% of its share value annually.
CVS Health Corporation has paid out, on average, around 26.52% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.07% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 2.07% return on their shares, in the form of dividend payments. In CVS Health Corporation's case, that would currently equate to about $2 per share.
While CVS Health Corporation's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.
CVS Health Corporation's most recent dividend payout was on 31 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 19 January 2022 (the "ex-dividend date").
CVS Health Corporation's shares were split on a 2:1 basis on 6 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CVS Health Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CVS Health Corporation shares which in turn could have impacted CVS Health Corporation's share price.
Over the last 12 months, CVS Health Corporation's shares have ranged in value from as little as $66.7817 up to $107.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CVS Health Corporation's is 0.8414. This would suggest that CVS Health Corporation's shares are less volatile than average (for this exchange).
Subscribe to trending stock alerts for a chance to win
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Ever wondered how to buy shares in Telefónica? We explain how and compare a range of providers that can give you access to many brands, including Telefónica.
Ever wondered how to buy shares in TSMC? We explain how and compare a range of providers that can give you access to many brands, including Taiwan Semiconductor.
Everything we know about the Mobileye IPO, plus information on how to buy shares.
Ever wondered how to buy shares in Banco Bilbao Vizcaya Argentaria? We explain how and compare a range of providers that can give you access to many brands, including BBVA.
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
This guide provides step-by-step instructions on how to buy Dent, lists some exchanges where you can get it and provides daily price data on DENT.
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Everything we know about the Polestar IPO, plus information on how to buy shares.
Ever wondered how to buy shares in STAG Industrial? We explain how and compare a range of providers that can give you access to many brands, including STAG Industrial.
